P
Paul Montgomery
Researcher at GlaxoSmithKline
Publications - 4
Citations - 1205
Paul Montgomery is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Lamotrigine & Lithium (medication). The author has an hindex of 3, co-authored 4 publications receiving 1163 citations.
Papers
More filters
Journal ArticleDOI
A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Manic or Hypomanic Patients With Bipolar I Disorder
Charles L. Bowden,Joseph R. Calabrese,Gary S. Sachs,Lakshmi N. Yatham,Shaheen Asghar,Magne Hompland,Paul Montgomery,N. Earl,Tonya M. Smoot,Joseph DeVeaugh-Geiss +9 more
TL;DR: Both lamotrigine and lithium were superior to placebo for the prevention of relapse or recurrence of mood episodes in patients with bipolar I disorder who had recently experienced a manic or hypomanic episode.
Journal ArticleDOI
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder
Joseph R. Calabrese,Charles L. Bowden,Gary S. Sachs,Lakshmi N. Yatham,Kirsten Behnke,Olli Pekka Mehtonen,Paul Montgomery,John A. Ascher,Walter Paska,N. Earl,Joseph DeVeaugh-Geiss,Joseph DeVeaugh-Geiss +11 more
TL;DR: Lamotrigine and lithium were superior to placebo for the prevention of mood episodes in bipolar I patients, with lamot Rigine predominantly effective against depression and lithium predominantly effectiveagainst mania.